MamaMancini's Holdings Financials

MMMB Metrics, Comps, Filings

Quarterly | Annual

Business

MamaMancini's Holdings, Inc. (formerly Mascot Properties, Inc.) was incorporated in the State of Nevada on July 22, 2009. Mascot Properties, Inc.'s (“Mascot”) activities since its inception consisted of trying to locate real estate properties to manage, primarily related to student housing, and services which included general property management, maintenance and activities coordination for residents. Mascot did not have any significant development of such business and did not derive any revenue. Due to the lack of results in its attempt to implement its original business plan, management determined it was in the best interests of the shareholders to look for other potential business opportunities.

On February 22, 2010, MamaMancini's LLC was formed as a limited liability company under the laws of the state of New Jersey in order to commercialize our initial products. On March 5, 2012, the members of MamaMancini's, LLC, holders of 4,700 units (the “Units”) of MamaMancini's LLC, exchanged the Units for 15,000,000 shares of common stock and those certain options to purchase an additional 223,404 shares of MamaMancini's Inc. (the “Exchange”). Upon consummation of the Exchange, MamaMancini's LLC ceased to exist and all further business has been and continues to be conducted by MamaMancini's Inc.

On January 24, 2013, Mascot, Mascot Properties Acquisition Corp, a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”), MamaMancini's Inc., a privately-held Delaware Corporation headquartered in New Jersey (“Mama's”) and David Dreslin, an individual (the “Majority Shareholder”), entered into an Acquisition Agreement and Plan of Merger (the “Agreement”) pursuant to which the Merger Sub was merged with and into Mama's, with Mama's surviving as a wholly-owned subsidiary of the Company (the “Merger”). The transaction (the “Closing”) took place on January 24, 2013 (the “Closing Date”). Mascot acquired, through a reverse triangular merger, all of the outstanding capital stock of Mama's in exchange for issuing Mama's shareholders (the “Mama's Shareholders”), pro-rata, a total of 20,054,000 shares of the Company's common stock. As a result of the Merger, the Mama's Shareholders became the majority shareholders of Mascot.

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
BlackRidge Technology (BRTI)	23,968	100%	-2.4	-206%	11,365	25,437	298	297	-23,371	-10,074	23,759
Lifeloc Technologies (LCTC)	23,947	47%	25.4	4%	9,024	2,457	6,665	3,152	401	883	22,405
Sierra Monitor (SRMC)	23,849	59%	29.1	3%	11,778	2,813	17,068	10,151	301	742	21,593
Heritage Global (HGBL)	23,776	0%	5.4	15%	22,548	11,416	20,597	0	3,322	3,704	19,875
Standard Metals Processing (SMPR)	23,655		-790.6	-24%	3,905	20,231	0	0	-941	-30	23,653
Bionik Laboratories (BNKL)	23,610		7.9	6%	35,234	3,260	0	1,857	2,167	2,391	18,935
Znergy (ZNRG)	23,572	14%	-7.3	-336%	1,025	1,831	1,222	173	-3,443	-3,246	23,566
Draper Oakwood Technology Acquisition (DOTA)	23,547		-218.6	-0%	58,936	53,936	0	0	-160	-108	23,539
Barington/Hilco Acquisition (BHAC)	23,189		-6.7	-22%	9,481	4,481	0	0	-2,081	-2,081	13,844
MamaMancini's Holdings (MMMB)	23,106	32%	21.1	11%	10,462	10,399	24,731	7,963	1,123	1,303	27,501
Nukkleus (NUKK)	23,049	2%	-46.5	-136%	324	1,307	19,200	300	-439	-495	23,040
Astro Aerospace (ASDN)	23,044		-3.2	759,640,700%			0	0	-7,596	-7,143	23,019
Blue Eagle Lithium (BEAG)	23,028		-51.1	-47%	967	634	0	0	-451	-451	23,027
GB Sciences (GBLX)	22,981	-23%	-1.8	-56%	29,840	15,525	3,909	-891	-16,597	-12,951	23,417
Reviv3 Procare (RVIV)	28,900	44%	-191.0	-20%	741	64	993	440	-150	-150	28,554
Cincinnati Bancorp (CNNB)	22,632		2.8	0%	221,474	197,766	0	0	458	2,707	7,626
Trident Brands (TDNT)	22,618	18%	-4.5	-128%	5,394	24,698	2,093	371	-6,884	-4,623	20,964
Synergy CHC (SNYR)	22,472	71%	9.6	11%	16,623	10,696	23,170	16,532	1,894	2,827	27,247
Hedgepath Pharmaceuticals (HPPI)	22,227		-9.9	-141%	1,484	3,359	0	0	-2,098	-2,098	20,855


Balance Sheet ($'000)	2011-09-30	2012-03-31	2012-09-30	2012-12-31	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-04-30	2014-07-31	2014-10-31	2015-01-31	2015-04-30	2015-07-31	2015-10-31	2016-01-31	2016-04-30	2016-07-31	2016-10-31	2017-01-31	2017-04-30	2017-07-31	2017-10-31	2018-01-31	2018-04-30	2018-07-31	2018-10-31	2019-01-31	2019-04-30	2019-07-31	2019-10-31
Cash	0	0	2	0	2,008	668	184	1,918	1,742	1,080	115	216	855	400	397	387	587	502	264	655	667	436	639	559	581	479	347	460	609	687	635	611
Accounts Receivable					464	814	645	1,060	1,064	1,144	1,054	2,312	2,233	1,265	1,216	1,379	1,477	1,725	1,360	1,871	1,818	2,302	3,065	2,859	3,085	3,782	1,750	3,223	2,699	2,336	2,711	3,298
Inventory					77	99	91	51	112	404	469	213	301	469	330	325	253	507	408	460	444	181	235	361	824	1,123	1,280	1,005	1,396	1,460	1,465	1,651
PP&E					40	40	117	485	982	1,116	1,258	1,299	1,352	1,417	1,452	1,556	1,560	1,578	1,764	1,786	2,037	2,280	2,379	3,302	4,575	4,995	5,509	5,631	5,638	5,935	5,982	6,095
Assets	0	0	2	0	2,982	2,212	1,630	4,403	5,124	5,394	4,975	6,132	6,936	5,675	5,448	5,505	5,794	6,091	5,532	6,347	6,319	6,750	7,473	7,620	7,272	8,357	6,812	7,957	7,764	9,346	9,626	10,462
Accounts Payable
Long-Term Debt																219	4,401	4,773	4,568	5,200	4,883	4,845	5,282	5,029	5,750	5,988	5,461	5,490	5,970	5,413	5,011	5,006
Liabilities	36	42	50	55	529	665	681	407	823	788	711	2,568	4,773	4,566	4,500	5,496	5,171	5,447	4,964	5,583	5,320	5,532	6,173	6,035	9,207	9,886	8,513	9,254	8,946	10,156	9,999	10,399
Stockholders' Equity	-36	-42	-48	-55	2,453	1,546	949	3,996	4,301	4,607	4,264	3,565	2,163	1,110	949	9	623	643	568	764	999	1,218	1,299	1,585	-1,935	-1,528	-1,702	-1,296	-1,182	-809	-373	63


Income Statement ($'000)	2011-09-30	2012-03-31	2012-09-30	2012-12-31	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-04-30	2014-07-31	2014-10-31	2015-01-31	2015-04-30	2015-07-31	2015-10-31	2016-01-31	2016-04-30	2016-07-31	2016-10-31	2017-01-31	2017-04-30	2017-07-31	2017-10-31	2018-01-31	2018-04-30	2018-07-31	2018-10-31	2019-01-31	2019-04-30	2019-07-31	2019-10-31
Revenue	0	0	0	0		1,772	1,700	2,168	3,102	2,583	2,665	3,760	3,747	3,353	2,739	3,238	3,273	3,924	4,824	4,576	5,410	5,357	7,005	7,351	7,829	7,742	5,641	8,243		7,365	8,099	9,267
Cost of Revenue						1,282	1,186	1,543	2,180	1,780	1,828	2,705	2,727	2,408	2,091	2,256	2,251	2,449	2,966	2,892	3,442	3,458	4,995	4,991	4,839	4,913	3,579	5,555		4,934	5,408	6,366
Gross Profit						490	515	624	922	803	837	1,054	1,020	945	648	982	1,022	1,475	1,858	1,684	1,968	1,900	2,010	2,360	2,991	2,829	2,062	2,687		2,371	2,691	2,901
R&D						3	4	5	7	19	38	29	29	23	20	34	30	31	37	39	38	26	25	28	60	30	37	32		25	25	33
SG&A	4	1	1	3	3,264	1,096	2,357	3,462	2,004	1,468	1,762	1,774	2,542	1,783	1,391	1,306	1,269	1,500	6	15	15	15	15	15	2,808	2,245	1,895	2,120		1,866	2,216	2,365
Tax	0		0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0
Net Income	-12	-3	2	-7	-1,982	-611	-753	-494	-1,090	-701	-793	-774	-1,792	-1,095	-1,000	-976	-441	-226	473	81	133	128	24	203	-36	324	-210	356		356	358	409


Cash Flow ($'000)	2011-09-30	2012-03-31	2012-09-30	2012-12-31	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-04-30	2014-07-31	2014-10-31	2015-01-31	2015-04-30	2015-07-31	2015-10-31	2016-01-31	2016-04-30	2016-07-31	2016-10-31	2017-01-31	2017-04-30	2017-07-31	2017-10-31	2018-01-31	2018-04-30	2018-07-31	2018-10-31	2019-01-31	2019-04-30	2019-07-31	2019-10-31
Cash Operating	-12		-3	-2	-2,071	-1,015	-1,569	-2,575	-1,241	-1,210	-1,180	-1,341	-1,276	-337	-427	-126	-371	-438	414	-123	629	527	-138	726	201	139	1,302	208		675	215	86
Cash Investing	0		0	0	-18	-325	-402	-849	-324	-81	-142	-41	-52	-65	-35	-103	-4	-19	-185	-22	-251	-667	-170	-523	-115	-420	-484	-122		-243	153	-74
Cash Financing	12		4	1	4,081	0	146	3,334	1,388	829	358	1,483	1,967	-53	459	219	576	372	-467	536	-367	-90	511	-284	-68	179	-950	28		-355	-419	-37

S-1	2020-02-07	Public Filing
10-K	2020-01-31	Filed 2020-04-23
10-Q	2019-10-31	Filed 2019-12-09
10-Q	2019-07-31	Filed 2019-09-12
10-Q	2019-04-30	Filed 2019-06-14
10-K	2019-01-31	Filed 2019-04-23
10-Q	2018-10-31	Filed 2018-12-11
10-Q	2018-07-31	Filed 2018-09-14
10-Q	2018-04-30	Filed 2018-06-13
10-K	2018-01-31	Filed 2018-05-16
10-Q	2017-10-31	Filed 2017-12-14
10-Q	2017-07-31	Filed 2017-09-14
10-Q	2017-04-30	Filed 2017-06-13
10-K	2017-01-31	Filed 2017-03-23
10-Q	2016-10-31	Filed 2016-12-15
10-Q	2016-07-31	Filed 2016-09-13
10-Q	2016-04-30	Filed 2016-06-13
10-K	2016-01-31	Filed 2016-04-21
10-Q	2015-10-31	Filed 2015-12-11
10-Q	2015-07-31	Filed 2015-09-14
10-Q	2015-04-30	Filed 2015-06-12
10-K	2015-01-31	Filed 2015-05-01
10-Q	2014-10-31	Filed 2014-12-22
10-Q	2014-07-31	Filed 2014-09-08
10-Q	2014-04-30	Filed 2014-06-12
10-K	2013-12-31	Filed 2014-03-20
10-Q	2013-09-30	Filed 2013-11-14
10-Q	2013-06-30	Filed 2013-08-14
10-Q	2013-03-31	Filed 2013-05-09
10-K	2012-12-31	Filed 2013-04-16
10-Q	2012-12-31	Filed 2013-01-23
10-Q	2012-09-30	Filed 2012-11-13
10-K	2012-06-30	Filed 2012-09-24
10-Q	2012-03-31	Filed 2012-05-15
10-Q	2011-12-31	Filed 2012-02-06
10-Q	2011-09-30	Filed 2011-11-09

8-K	2020-05-06	Other Events, Other Events, Exhibits
8-K	2019-05-01	Enter Agreement, Exhibits, Enter Agreement, Exhibits
8-K	2019-01-04	Off-BS Arrangement, Exhibits, Exhibits
8-K	2018-09-17	Enter Agreement, Enter Agreement, Exhibits
8-K	2018-01-22	Officers, Exhibits